Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | RMD | ResMed Common Stock | Award | $0 | +4.47K | +69.43% | $0.00 | 10.9K | Aug 15, 2024 | Direct | F1 |
transaction | RMD | ResMed Common Stock | Award | $0 | +476 | +4.36% | $0.00 | 11.4K | Aug 15, 2024 | Direct | F2 |
Id | Content |
---|---|
F1 | Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met. Stock units vest1/3each year on the anniversary of the grant. |
F2 | Represents performance-based restricted stock units granted on November 16, 2023. The shares were earned on August 15, 2024, when the compensation committee certified that the performance metrics were met for this portion ofthegrant. The earned units remain subject to time-vesting requirements, and are scheduled to vest on the three-year anniversary of the grant, assuming continued service through the vesting date. |